Drawing for HEARTSHEET

USPTO serial 90776728

HEARTSHEET

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MEYERS, MORGAN LAURA
Law office
TMEG LAW OFFICE 102

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HEARTSHEET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John E. Lyhus

John E. Lyhus FITCH, EVEN, TABIN & FLANNERY LLP120 S. LASALLE STREETSUITE 2100CHICAGO, IL 60603

Goods and services

ClassDescriptionStatusFirst use
005Biological tissue and cell grafts; Reagents for medical and clinical medical use; Kits comprised of reagents for medical and clinical use in the field of cell and tissue regenerationACTIVE—
010Artificial vascular grafts; Artificial biomaterials for augmentation of bone and tissue for medical purposes; Apparatus for the regeneration of cells for medical purposesACTIVE—
040(Based on Section 44(e)) Treatment of human cells and tissue of cultured tissue graft by in vitro culture of cells obtained from patients themselves for surgical implants; Biomanufacturing for others, namely, manufacturing of tissue and cell grafts using combinations of biological cells obtained from the patients themselves and artificial materials in the in vitro manufacturing process; (Based on Section 1(b)) Treatment of cells and tissue for surgical implants; Biomanufacturing for others, namely, manufacturing of tissue and cell grafts using combinations of biological and artificial materials in the manufacturing processACTIVE—
042(Based on Section 1(b) and Section 44(e)) Medical research; Biological research; Pharmaceutical research; Biomedical research; Biomedical research and consulting in the field of cell regeneration; Biomedical research and consulting in the field of cell culture grafting; (Based on Section 1(b)) Testing and inspection of medical, biological, cell and tissue grafting, and cell regeneration processes and productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 14, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 14, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 26, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 25, 2025EX5GSOU EXTENSION 5 GRANTED—
Mar 25, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 27, 2024EXT5SOU EXTENSION 5 FILED—
Nov 27, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 15, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 14, 2024EX4GSOU EXTENSION 4 GRANTED—
May 14, 2024EXT4SOU EXTENSION 4 FILED—
May 14, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 24, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 22, 2023EX3GSOU EXTENSION 3 GRANTED—
Nov 22, 2023EXT3SOU EXTENSION 3 FILED—
Nov 22, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 26, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 24, 2023EX2GSOU EXTENSION 2 GRANTED—
May 24, 2023EXT2SOU EXTENSION 2 FILED—
May 24, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 30, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 28, 2022EX1GSOU EXTENSION 1 GRANTED—
Nov 28, 2022EXT1SOU EXTENSION 1 FILED—
Nov 28, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 7, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 12, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 12, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 23, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 8, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 8, 2022DOCKASSIGNED TO EXAMINER—
Sep 2, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 19, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance